Home
News
Create
Screeners
Insights
Lactose
113.
00
-4.55
(-3.87%)
Market Cap
₹142.27 Cr
PE Ratio
30.61
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-3.87%
1M
+37.89%
6M
-6.57%
1Y
-5.08%
5Y
+325.61%
View Company Insights
Latest news about Lactose
Lactose (India) Limited Submits Q4 FY26 Securities Dematerialization Certificate to BSE
10 days ago
Lactose (India) Limited filed its Q4 FY26 securities dematerialization certificate with BSE under SEBI Regulation 74(5) on April 13, 2026. Company Secretary Ritesh Pandey submitted the certificate confirming proper furnishing of dematerialization details for the quarter ended March 31, 2026. Registrar Bigshare Services Private Limited provided supporting confirmation, verifying compliance with dematerialization procedures and regulatory requirements for securities processing.
Lactose India EGM Approves Vitanosh Merger with Overwhelming Shareholder Support
Mar 31, 2026
Lactose India Adopts New Business Line in Specialized Pharmaceutical Excipients with ₹15 Crore Investment
Jan 30, 2026
SST Private Family Trust Completes SEBI Disclosure for Lactose India Stake Transfer
Jan 16, 2026
Lactose India Limited's Credit Rating Reaffirmed at CRISIL BBB-/Stable
Oct 24, 2025
More news about Lactose
23
Aug 25
Lactose (India) Limited Secures BSE Approval for Vitanosh Ingredients Merger
Lactose (India) Limited has received a no-objection observation letter from BSE Limited for its proposed merger with Vitanosh Ingredients Private Limited. The BSE issued the letter on August 22, 2025, containing no adverse observations. The merger scheme, approved by the Board of Directors in October 2024, falls under Sections 230 to 232 of the Companies Act, 2013. While this is a significant step, the merger still requires additional regulatory and statutory approvals. The company has made the BSE observation letter available on its website for transparency.
Lactose
113.
00
-
4.
55
(-
3.
87
%)
1 Year Returns:
-5.08%
Industry Peers
Sun Pharmaceutical
1,620.40
(-
3.
55
%)
Divis Laboratories
6,361.50
(-
0.
27
%)
Torrent Pharmaceuticals
4,117.20
(-
0.
72
%)
Dr Reddys Laboratories
1,317.10
(-
1.
04
%)
Lupin
2,296.10
(-
1.
93
%)
Cipla
1,295.00
(-
0.
83
%)
Mankind Pharma
2,267.40
(-
1.
11
%)
Zydus Life Science
927.40
(-
2.
00
%)
Aurobindo Pharma
1,413.80
(-
1.
50
%)
Glenmark Pharmaceuticals
2,299.50
(-
1.
52
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO